92
Participants
Start Date
October 1, 2025
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2026
Radiation
Subjects ≥ 3 years of age with a diffuse, intrinsic brain stem glioma will receive radiation.
Atengenal
Subjects ≥ 3 years of age with a diffuse, intrinsic brain stem glioma will receive Atengenal in combination with Astugenal (Antineoplaston therapy) and radiation
Astugenal
Subjects ≥ 3 years of age with a diffuse, intrinsic brain stem glioma will receive Astugenal in combination with Atengenal (Antineoplaston therapy) and radiation
Lead Sponsor
Burzynski Research Institute
OTHER